• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

ADA Standards of Care in Diabetes 2024: A Guideline Topline


For primary care clinicians, this Guideline Topline provides a summary of 2024 ADA Standard of Care updates that may support improved outcomes in your practice.

The Standards of Care in Diabetes from the American Diabetes Association (ADA) is updated annually to reflect advances in therapeutics and technology and to include shifts in focus or emphasis in the clinical management of type 2 diabetes (T2D). Strategies for diagnosing diabetes are coupled with methods to prevent or delay T2D onset and its associated comorbidities.

Among updates to the 2024 iteration of the guidelines are recommendations for use of new classes of antiobesity drugs and on overall management of obesity in people with diabetes, including reducing "therapeutic inertia", providing more personalized approaches, and evaluating additional measures of obesity than body mass index (BMI).

The ADA updated Standards also encourage health care providers to become familiar with new diabetes technology, and to embrace telehealth and digital tools for diabetes self-management education.

The Guideline Topline slide show above does not cover the entire Standards document but instead offers a snapshot of numerous recommendations that may help improve outcomes in primary care.

Source: American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes—2024. Diabetes Care 2024;47(Supp1):S1-321.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.